Indian drugmaker Cipla's fourth-quarter profit misses view on weak US sales
Indian drugmaker Cipla's fourth-quarter profit misses view on weak US sales
Indian drugmaker Cipla's fourth-quarter profit misses view on weak US sales
Sector
HEALTHCARE
News Type
MARKET
Impact Level
MEDIUM
AI Sentiment
NEGATIVE
Published
13 May 2026
📎 Sources
Reuters | https://www.tradingview.com/news/reuters.com,2026:newsml_L6N41Q0J9:0-indian-drugmaker-cipla-s-fourth-quarter-profit-misses-view-on-weak-us-sales/